Fig. 11
From: Cancer Organoids as reliable disease models to drive clinical development of novel therapies
Organotypic tissue slices as preclinical model to test autophagy drugs. Illustration of the experimental workflow used in the study. Immunohistochemistry of activated Caspase 3 was used as a marker of apoptotic cell death. Figure created with biorender.com